Cormedix Inc (CRMD) Stock Price, Quote & News

Company Profile

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was in...

Industry: Biotechnology

Sector: Healthcare

Phone: 908 517 9500

Fax: 908 375 8272

Website: www.cormedix.com

Address:

300 Connell Drive, Suite 4200, Berkeley Heights, United States

look_at_that_ Jul. 30 at 1:59 AM

$CRMD I anticipate Fresenius is going to be scaling way beyond 6k patients and possibly to all CVC patients like Serge from Needham hinted at. He also mentioned the company is negotiating with the other LDO. I don’t think that is an insignificant or a poorly worded statement. We’ll know more in about two weeks but I have a feeling it’s going to be a great call.

1 · Reply

Miketj Jul. 30 at 12:40 AM

$CRMD tight bands… IMO big move coming. Maybe getting that 20% day sooner than later, hoping for the move to be towards upper bollinger band. GLA

1 · Reply

Motorhead419 Jul. 30 at 12:37 AM

$CRMD All the BS... When we see $20 I'm gonna sell 5000 of my 6000 shares. My average is $6.. I hope we'll see $20 and higher.😳

3 · Reply

paynespleasurepalace Jul. 29 at 10:44 PM

$CRMD ChatGPT valuation: ✅ Conclusion A fair valuation for CorMedix stock today (as of July 29, 2025) lies in the $17–$20 per share range, with a conservative floor around $15. At current quote (~$11.60–$12.00), this implies a potential 40%–70% upside, assuming stable fundamentals and achievement of growth milestones.

0 · Reply

BeeeeDooooh Jul. 29 at 8:41 PM

$CRMD give us preliminary Q2… let us rise, and then consolidate, then during Q2 ER give us 2H guidance and tell us about the offering for the next leg up. Start playing chess, not checkers, Joe!

1 · Reply

wolfofwestloop Jul. 29 at 8:31 PM

$CRMD I'm not sure what the missing ingredient is with this stock but to still continuously get manipulated like this is a bit surprising...

2 · Reply

trd4dollaBulls Jul. 29 at 8:29 PM

$CRMD - unreal!!!🙄

1 · Reply

TSLA_S3XY Jul. 29 at 8:17 PM

$CRMD Another Day Closer!

0 · Reply

erpy Jul. 29 at 7:53 PM

$CRMD great time to buy jmho. Way over sold rsi is at 20. Shorts are playing with fire jmho.

1 · Reply

altair787 Jul. 29 at 7:50 PM

$CRMD Just came back today after doing some accounting maintenance. What the hell happened?

1 · Reply

CorMedix Analyst Says Investors Could Be Further Rewarded

Jun 30, 2025, 2:14 PM EDT - 4 weeks ago

CorMedix Seems Significantly Undervalued

Jun 27, 2025, 9:09 AM EDT - 4 weeks ago

Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session

CNXC

Jun 27, 2025, 8:00 AM EDT - 4 weeks ago

CorMedix Inc. Announces Pricing of Public Offering of Common Stock

Jun 26, 2025, 4:01 PM EDT - 4 weeks ago

CorMedix Inc. Announces Proposed Public Offering of Common Stock

Jun 23, 2025, 7:30 AM EDT - 5 weeks ago

CorMedix inc. Announces Customer Implementation

Jun 5, 2025, 12:37 AM EDT - 7 weeks ago

CorMedix: DefenCath In Exponential Growth Phase With Robust Market Position

Jun 4, 2025, 12:41 PM EDT - 7 weeks ago

CorMedix: Exceeding Expectations

May 30, 2025, 8:30 AM EDT - 2 months ago

CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

May 15, 2025, 8:30 AM EDT - 2 months ago

CorMedix Inc. to Participate in the RBC Global Healthcare Conference

May 6, 2025, 11:59 AM EDT - 3 months ago

CorMedix, Inc. (CRMD) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:30 AM EDT - 3 months ago

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Apr 29, 2025, 8:30 AM EDT - 3 months ago

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025

Apr 8, 2025, 7:30 AM EDT - 4 months ago

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

Apr 2, 2025, 8:30 AM EDT - 4 months ago

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 3:01 AM EDT - 4 months ago

CorMedix: A Fair-Priced Biotech Company With A Bright Future

Mar 25, 2025, 10:51 AM EDT - 4 months ago

CorMedix Inc. (CRMD) Q4 2024 Earnings Call Transcript

Mar 25, 2025, 7:30 AM EDT - 4 months ago

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 24, 2025, 9:21 AM EDT - 4 months ago

CorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Mar 18, 2025, 8:30 AM EDT - 4 months ago

CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025

Jan 7, 2025, 7:30 AM EST - 7 months ago

CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update

Dec 19, 2024, 8:30 AM EST - 7 months ago

CorMedix Inc. Added to Nasdaq Biotechnology Index

Nov 26, 2024, 8:30 AM EST - 8 months ago

CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products

Nov 8, 2024, 8:00 AM EST - 9 months ago

Stock Picks From Seeking Alpha's October 2024 New Analysts

ACGL AMCX AMPS APOG AVRE BHP BILL

Nov 4, 2024, 8:30 AM EST - 9 months ago

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

Oct 30, 2024, 12:32 PM EDT - 9 months ago

CorMedix Inc. (CRMD) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 7:30 AM EDT - 9 months ago

CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update

Oct 28, 2024, 1:33 PM EDT - 9 months ago

CorMedix 2.0: New Leadership, New Approval, New Focus

Oct 25, 2024, 2:30 PM EDT - 9 months ago

Undercovered Dozen: CorMedix, Cabaletta, Skyx Platforms, Dynex Capital +

Oct 24, 2024, 8:30 AM EDT - 9 months ago

CorMedix Inc. Announces New Data at ASN Kidney Week 2024

Oct 23, 2024, 8:30 AM EDT - 9 months ago

CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024

Sep 13, 2024, 8:30 AM EDT - 11 months ago

CorMedix Inc. to Present at the Cantor Global Healthcare Conference

Sep 9, 2024, 10:52 AM EDT - 11 months ago

CorMedix Inc. Announces New Commercial Agreement

Aug 14, 2024, 2:08 PM EDT - 1 year ago

CorMedix Inc. (CRMD) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 7:30 AM EDT - 1 year ago

CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update

Aug 7, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024

Jul 3, 2024, 8:00 AM EDT - 1 year ago

CorMedix Inc. Announces Outpatient Availability of DefenCath

Jun 6, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath

May 28, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider

May 11, 2024, 5:48 PM EDT - 1 year ago

CorMedix Inc. (CRMD) Q1 2024 Earnings Call Transcript

May 10, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Participate in Two Upcoming Investor Conferences

May 9, 2024, 7:30 AM EDT - 1 year ago

CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

look_at_that_ Jul. 30 at 1:59 AM

1 · Reply

Miketj Jul. 30 at 12:40 AM

$CRMD tight bands… IMO big move coming. Maybe getting that 20% day sooner than later, hoping for the move to be towards upper bollinger band. GLA

1 · Reply

Motorhead419 Jul. 30 at 12:37 AM

$CRMD All the BS... When we see $20 I'm gonna sell 5000 of my 6000 shares. My average is $6.. I hope we'll see $20 and higher.😳

3 · Reply

paynespleasurepalace Jul. 29 at 10:44 PM

0 · Reply

BeeeeDooooh Jul. 29 at 8:41 PM

$CRMD give us preliminary Q2… let us rise, and then consolidate, then during Q2 ER give us 2H guidance and tell us about the offering for the next leg up. Start playing chess, not checkers, Joe!

1 · Reply

wolfofwestloop Jul. 29 at 8:31 PM

$CRMD I'm not sure what the missing ingredient is with this stock but to still continuously get manipulated like this is a bit surprising...

2 · Reply

trd4dollaBulls Jul. 29 at 8:29 PM

$CRMD - unreal!!!🙄

1 · Reply

TSLA_S3XY Jul. 29 at 8:17 PM

$CRMD Another Day Closer!

0 · Reply

erpy Jul. 29 at 7:53 PM

$CRMD great time to buy jmho. Way over sold rsi is at 20. Shorts are playing with fire jmho.

1 · Reply

altair787 Jul. 29 at 7:50 PM

$CRMD Just came back today after doing some accounting maintenance. What the hell happened?

1 · Reply

golfguy42360 Jul. 29 at 7:48 PM

$CRMD Unplug the ATM Joe this ain't a fucking 7 eleven

0 · Reply

rulzart Jul. 29 at 7:48 PM

$CRMD don't like the look of that drop

0 · Reply

Vertical_Capital Jul. 29 at 7:16 PM

$CRMD $AMD $BABA $

1 · Reply

Czar100 Jul. 29 at 7:14 PM

$CRMD Only for a little while…..

0 · Reply

wolfofwestloop Jul. 29 at 7:03 PM

$CRMD Hopefully on the ER call JT provides an update of Q3 orders as well. He's going to have a lot to talk about. I hope he doesn't fumble it like he did with the Q4 call in March.

1 · Reply

maroonbulldog Jul. 29 at 6:46 PM

$CRMD Give us that cup and handle! Someone's going to get teabagged 😂

0 · Reply

BioLove Jul. 29 at 6:37 PM

$CRMD U-shape days before positively anticipated earnings are usually a great thing

0 · Reply

Croesus Jul. 29 at 6:30 PM

$CRMD

0 · Reply

erpy Jul. 29 at 6:02 PM

$CRMD I Think the company is its bet position ever right now. Still fantastic opportunity to get your position. Jmho, but its getting closer! LFG

1 · Reply

BeeeeDooooh Jul. 29 at 5:55 PM

$CRMD technicals look pretty similar today compared to mid-April. fundamentals much better and $4 higher SP. 🤷🏼‍♂️

0 · Reply

PangeaProxima Jul. 29 at 5:48 PM

$CRMD maxed and relaxed, any day now

0 · Reply

alwaysgood2know Jul. 29 at 5:21 PM

$CRMD green by eod!

0 · Reply

Market Cap	812.54M
Revenue (ttm)	43.47M
Net Income (ttm)	-17.93M
EPS (ttm)	N/A
PE Ratio	52.23
Forward PE	11.89
Profit Margin	-41.25%
Debt to Equity Ratio	0.00

Volume	1,505,200
Avg Vol	1,945,298
Day's Range	N/A - N/A
Shares Out	67.83M
Stochastic %K	69%
Beta	1.58
Analysts	Strong Sell
Price Target	$19.33